Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter

Amphetamine (AMPH) inhibits uptake and causes release of dopamine (DA) from presynaptic terminals. AMPH can act on both vesicular storage of DA and directly on the dopamine transporter (DAT). To assess the relative importance of these two processes, we have examined the releasing actions of AMPH in mice with a genetic deletion of the DAT. The sequence of actions of AMPH has been determined by following the real time changes of DA in the extracellular fluid of intact tissue with fast scan cyclic voltammetry. In striatal slices from wild-type mice, AMPH causes a gradual (∼30 min) increase in extracellular DA, with a concomitant disappearance of the pool of DA available for depolarization-evoked release. Conversely, in slices from mice lacking the DAT, although a similar disappearance of electrically stimulated DA release occurs, extracellular DA does not increase. Similarly, microdialysis measurements of DA after AMPH in freely moving animals show no change in mice lacking the DAT, whereas it increases 10-fold in wild-type mice. In contrast, redistribution of DA from vesicles to the cytoplasm by the use of a reserpine-like compound, Ro4–1284, does not increase extracellular DA in slices from wild-type animals; however, subsequent addition of AMPH induces rapid (<5 min) release of DA. Thus, the DAT is required for the releasing action, but not the vesicle-depleting action, of AMPH on DA neurons, and the latter represents the rate-limiting step in the effects of AMPH. Furthermore, these findings suggest that in the absence of pharmacological manipulation, such as the use of amphetamine, endogenous cytoplasmic DA normally does not reach sufficient concentrations to reverse the DAT.

[1]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[2]  R. Gainetdinov,et al.  Dopamine Transporter Is Required for In Vivo MPTP Neurotoxicity: Evidence from Mice Lacking the Transporter , 1997, Journal of neurochemistry.

[3]  W. Wetsel,et al.  Anterior Pituitary Hypoplasia and Dwarfism in Mice Lacking the Dopamine Transporter , 1997, Neuron.

[4]  P. Kalivas,et al.  Repeated Cocaine Modifies the Mechanism by which Amphetamine Releases Dopamine , 1997, The Journal of Neuroscience.

[5]  M. Kavanaugh,et al.  Multiple Ionic Conductances of the Human Dopamine Transporter: The Actions of Dopamine and Psychostimulants , 1997, The Journal of Neuroscience.

[6]  J. B. Justice,et al.  Human norepinephrine transporter kinetics using rotating disk electrode voltammetry. , 1996, Analytical chemistry.

[7]  E. Floor,et al.  Amphetamine releases dopamine from synaptic vesicles by dual mechanisms , 1996, Neuroscience Letters.

[8]  S. Amara,et al.  Channels in transporters , 1996, Current Opinion in Neurobiology.

[9]  T. Bonner,et al.  Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Mark Wightman,et al.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.

[11]  P. Garris,et al.  Different effects of cocaine and nomifensine on dopamine uptake in the caudate-putamen and nucleus accumbens. , 1995, The Journal of pharmacology and experimental therapeutics.

[12]  P. Garris,et al.  Comparison of Dopamine Uptake in the Basolateral Amygdaloid Nucleus, Caudate‐Putamen, and Nucleus Accumbens of the Rat , 1995, Journal of neurochemistry.

[13]  D. Sulzer,et al.  Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[14]  G. Chiara,et al.  Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: Evidence from microdialysis and Fos immunohistochemistry , 1995, Neuroscience.

[15]  Z. Kruk,et al.  Effects of Amphetamine on Carrier‐Mediated and Electrically Stimulated Dopamine Release in Slices of Rat Caudate Putamen and Nucleus Accumbens , 1995, Journal of neurochemistry.

[16]  O. Hornykiewicz,et al.  Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. , 1995, Molecular pharmacology.

[17]  W. Chen,et al.  Dynamic Storage of Dopamine in Rat Brain Synaptic Vesicles In Vitro , 1995, Journal of neurochemistry.

[18]  E. Filinger Effect of a reserpine-like agent on the release and metabolism of [3H]NA in cell bodies and terminals. , 1994, General pharmacology.

[19]  R. Edwards,et al.  The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. , 1994, The Journal of biological chemistry.

[20]  K. Neve,et al.  Release of dopamine via the human transporter. , 1994, Molecular pharmacology.

[21]  G. Rudnick,et al.  Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters. , 1993, Molecular pharmacology.

[22]  R. Wightman,et al.  Principles of voltammetry and microelectrode surface states , 1993, Journal of Neuroscience Methods.

[23]  A. Cesura,et al.  Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo. , 1993, The Journal of pharmacology and experimental therapeutics.

[24]  D. Sulzer,et al.  Amphetamine and Other Weak Bases Act to Promote Reverse Transport of Dopamine in Ventral Midbrain Neurons , 1993, Journal of neurochemistry.

[25]  M. Caron,et al.  Molecular characterization of the dopamine transporter. , 1993, Trends in pharmacological sciences.

[26]  E. Pothos,et al.  Weak Base Model of Amphetamine Action , 1992, Annals of the New York Academy of Sciences.

[27]  E. D. De Souza,et al.  Interactions of [3H]amphetamine with rat brain synaptosomes. II. Active transport. , 1991, The Journal of pharmacology and experimental therapeutics.

[28]  E. D. De Souza,et al.  Interactions of [3H]amphetamine with rat brain synaptosomes. I. Saturable sequestration. , 1991, The Journal of pharmacology and experimental therapeutics.

[29]  A. Horn Dopamine uptake: A review of progress in the last decade , 1990, Progress in Neurobiology.

[30]  D. Sulzer,et al.  Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: A mechanism of action , 1990, Neuron.

[31]  D. Segal,et al.  Apomorphine Does Not Alter Amphetamine‐Induced Dopamine Release Measured in Striatal Dialysates , 1990, Journal of neurochemistry.

[32]  D. Segal,et al.  Reserpine enhances amphetamine stereotypies without increasing amphetamine-induced changes in striatal dialysate dopamine , 1989, Brain Research.

[33]  U. Ungerstedt,et al.  Ca2+ dependence of the amphetamine, nomifensine, and Lu 19-005 effect on in vivo dopamine transmission. , 1989, European journal of pharmacology.

[34]  F. Bloom,et al.  Cellular and molecular mechanisms of drug dependence. , 1988, Science.

[35]  S. Knepper,et al.  Inhibition of norepinephrine transport into synaptic vesicles by amphetamine analogs. , 1988, The Journal of pharmacology and experimental therapeutics.

[36]  U. Ungerstedt,et al.  In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. , 1988, European journal of pharmacology.

[37]  G. Arbuthnott,et al.  Amphetamine‐Induced Dopamine Release in the Rat Striatum: An In Vivo Microdialysis Study , 1988, Journal of neurochemistry.

[38]  L. Cubeddu,et al.  Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores. , 1986, The Journal of pharmacology and experimental therapeutics.

[39]  C. Rutledge,et al.  Evidence for carrier-mediated efflux of dopamine from corpus striatum. , 1982, Biochemical pharmacology.

[40]  C. Rutledge,et al.  Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine. , 1982, Biochemical pharmacology.

[41]  D. Clarke,et al.  In vivo monoamine oxidase inhibition by d-amphetamine. , 1980, Biochemical pharmacology.

[42]  A. Cho,et al.  Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. , 1979, The Journal of pharmacology and experimental therapeutics.

[43]  M. Raiteri,et al.  Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. , 1979, The Journal of pharmacology and experimental therapeutics.

[44]  A. Green,et al.  Inhibition of mouse brain monoamine oxidase by (+)‐amphetamine in vivo , 1978, The Journal of pharmacy and pharmacology.

[45]  G. Cohen,et al.  Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices. , 1975, Biochemical pharmacology.

[46]  K. E. Moore,et al.  D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo. , 1975, The Journal of pharmacology and experimental therapeutics.

[47]  S. Iversen,et al.  The pharmacological and anatomical substrates of the amphetamine response in the rat , 1975, Brain Research.

[48]  J. Scheel-Krüger,et al.  Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain. , 1971, European journal of pharmacology.

[49]  R. Wise,et al.  Addictive drugs and brain stimulation reward. , 1996, Annual review of neuroscience.

[50]  E. Nestler,et al.  Molecular mechanisms of drug reinforcement and addiction. , 1995, Annual review of neuroscience.

[51]  L S Seiden,et al.  Amphetamine: effects on catecholamine systems and behavior. , 1993, Annual review of pharmacology and toxicology.

[52]  S. Amara,et al.  Neurotransmitter transporters: recent progress. , 1993, Annual review of neuroscience.

[53]  J. B. Justice,et al.  Microdialysis compared with other in vivo release models , 1991 .

[54]  L. Cubeddu,et al.  Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores. , 1986, The Journal of pharmacology and experimental therapeutics.

[55]  C. Marsden Measurement of neurotransmitter release in vivo , 1984 .